000 01465 a2200397 4500
005 20250514055050.0
264 0 _c20030214
008 200302s 0 0 eng d
022 _a0887-378X
024 7 _a10.1111/1468-0009.00027
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBar-Shalom, Avital
245 0 0 _aPatents and innovation in cancer therapeutics: lessons from CellPro.
_h[electronic resource]
260 _bThe Milbank quarterly
_c2002
300 _a637-76, iii-iv p.
_bdigital
500 _aPublication Type: Journal Article; Legal Case; Research Support, Non-U.S. Gov't
650 0 4 _aBiomedical Research
_xeconomics
650 0 4 _aBiotechnology
_xeconomics
650 0 4 _aCancer Care Facilities
_xeconomics
650 0 4 _aEmbryo Research
_xlegislation & jurisprudence
650 0 4 _aFinancing, Government
650 0 4 _aHumans
650 0 4 _aIntellectual Property
650 0 4 _aLicensure
650 0 4 _aNational Institutes of Health (U.S.)
650 0 4 _aNeoplasms
_xtherapy
650 0 4 _aPatents as Topic
_xlegislation & jurisprudence
650 0 4 _aResearch Support as Topic
_xlegislation & jurisprudence
650 0 4 _aSocial Responsibility
650 0 4 _aStem Cells
650 0 4 _aUnited States
650 0 4 _aUniversities
700 1 _aCook-Deegan, Robert
773 0 _tThe Milbank quarterly
_gvol. 80
_gno. 4
_gp. 637-76, iii-iv
856 4 0 _uhttps://doi.org/10.1111/1468-0009.00027
_zAvailable from publisher's website
999 _c12334792
_d12334792